- AIG Board OKs CEO Pay; Benmosche Agrees to Stay
- Half of Banks' Losses May Still Be Hidden: IMF Head
- Deere Reports Quarterly Net Loss, Revenue Falls
- Tiffany Profit Higher Than Expected; Raises Outlook
- Americans Ditch Planes for Trains this Thanksgiving
- Obama Reiterates Commitment to Boost US-India Ties
- FDIC's Bair Cautions on Risks in Bank Break-Up Plan
- Call Me Crazy: Confessions of a Black Friday Shopper
- Turkey Day 101: How Well Do You Know Your Bird?
- Why You Should Play the Reflation Trade: Stock Picker
- Citi Mortgage Reveals What Treasury Won't
- S&P to Hit 1,200 by Year-End: Chief Investor
- Amended Berkshire Hathaway Filing Indicates No Secret Stock Stakes at End of Q3
- Facebook's Biggest-Ever Holiday Shopping Season
- Facebook's New Dual Class Structure - Slow Steps to an IPO
- 5 Big Bank Stocks Investors Should Consider: Strategists
- Gambling Drunk, Texting to Live And America's On Sale - Your Emails
- Nov. 24: Unusual Volume Leaders
MOST SHARED
- The 'Real' Jobless Rate: 17.5% Of Workers Are Unemployed
- Wednesday's Economic News Crunch Could Tilt Markets
- Obama Reiterates Commitment to Boost US-India Ties
- NBA D-League On The Rise
- Australia Wheat Exporters Face Challenges: GrainCorp
- Japan Export Rebound Eases Fear of New Recession
- Starbucks Eyes China as Next Major Market
- Stifling Anger at Work Can Kill, Survey Finds
- The Social Media Gaming Threat
Text Size 
Special to CNBC.com
Healthcare reform will bring slightly greater pricing pressure but larger volume for medical technology firms, says Steve Macmillan, CEO of Stryker.
Still, he worries that a hastily crafted reform bill may lead to unintended consequences in the long-run. "I hope we don't ram something through," he tells CNBC. (To hear the full interview, watch the video.)
Macmillan expects the Kalamazoo, Mich., medical equipment provider's clients—hospitals—to continue to conserve capital amidst uncertainty over healthcare reform through 2009, calling it a "digestion year" for hospitals.
Stryker [SYK
Loading...
()
], which operates in 120 countries, saw earnings fall by 4.7 percent but beat analysts' expectations. Macmillan says weaker purchases of hospital equipment were offset by steady growth in sales of orthopedic implants.
Macmillan defends the company's underlying fundamentals, arguing that regardless of reform, demand for orthopedic equipment will be fueled by aging baby boomers.
"We feel very good...people are going to need our products," he says.
Stryker is looking for opportunities for potential acquisitions, says Macmillan, who insists the company has plenty of cash on hand.
"We like our position to be able to be on the prowl during these times," he says.
For More on the Healthcare and Medical Services...
- In Rural America, Healthcare Reform May Be Critical
- Challenge to Health Bill Selling Reform
- Glaxo Profit Rises 11%, Topping Forecasts
- Pfizer's Profit Slightly Tops Forecasts
- Pharma's Market Blog with Mike Huckman
- Remember when auto shows were major events where new models could generate buzz?
- CNBC’s Mike Huckman visits a cutting-edge plant to see how the flu vaccine of the future is being made.
- People who bottle up their anger at work are up to five times more likely to suffer a heart attack, a study found.
- Playboy will outsource its publishing operations in a bid to become profitable again.
- A new McDonald's in Manhattan is the nation's first to sport a sleek, chic interior imported from stores in London and Paris.
- For nearly three decades, these on-call experts have been dishing advice on how to – and not to – cook turkey.
Data is a real-time snapshot *Data is delayed at least 15 minutes